BioNxt Solutions Reports Progress on BNT23001 Development for Multiple Sclerosis Treatment
BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE: BNXT) (OTC MARKETS: BNXTF) (FSE: BXT), a bioscience company spec…
Collaborative Breakthrough in Lung-on-Chip Technology
Collaborative Breakthrough in Lung-on-Chip Technology: AlveoliX, Vitrocell, University of Bern and Helmholtz Institute f…
Novel Liver Ring Trial Set to Revolutionize Drug Safety Assessment
In a first-of-its-kind initiative, TissUse (a leader in organ-on-chip technology) announced the commencement of the Live…
CELLphenomics and Charles River Announce Agreement, Expanding 3D In Vitro Services for Cancer Therapy Drug Screening
CELLphenomics and Charles River Laboratories International, Inc. (NYSE: CRL) announced an agreement, that provides Charl…
Advancements in 3D Cell Culture Market: Pioneering Applications and Market Trends from 2023 to 2027
The Global 3D Cell Culture Market is expected to witness a double-digit growth rate by 2027. Some of the key factors dri…
Ubisoft reports full-year 2022-23 earnings figures
. - Pivotal year as Ubisoft reinforced focus on biggest opportunities - FY24 line-up to reflect key strategic priorities…
CELLphenomics’ and KYAN Therapeutics combined platforms provide best-in-class solutions to support the biopharma industry
CELLphenomics and KYAN Therapeutics announced their new partnership today. By combining KYAN's technology platform, Opti…
4SC - Clinical Study Presentations at the 31. German Conference of Skin Cancer (31. Hautkrebskongress)
* MERKLIN1: Trial in progress e-poster (ID 123) and oral presentation entitled "A phase II, open label, multicenter stud…
VITROCELL® AES for toxicity testing of airborne particles
DOI:10.3791/61210 Hedwig M. Braakhuis1, Ruiwen He1,2, Rob J. Vandebriel1, Eric R. Gremmer1, Edwin Zwart1, Jolanda P. V…
Testing Tea for Safety and Quality
The GBA Group provides a team of experts that deals with the constantly changing requirements in the tea sector every da…